Actively Recruiting

Phase Not Applicable
Age: 18Years - 39Years
MALE
NCT06338475

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

Led by University of California, Irvine · Updated on 2025-03-25

100

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Building upon the results of a single-arm trial designed to investigate the feasibility and acceptability of a novel intervention, Goal-focused Emotion-Regulation Therapy (GET), this trial is a randomized-controlled biobehavioral pilot trial of GET versus a time-and attention matched control (Instrumental Supportive Listening; ISL) in Latino/Hispanic young adult survivors of adolescent and young adult (AYA) cancer (age 15-39 years at diagnosis). Outcomes include improved distress symptoms, emotion regulation, goal navigation skills, and changes in stress-sensitive biomarkers. Participants will be randomized to receive six sessions of GET or ISL delivered over eight weeks. In addition to indicators of intervention feasibility, the investigators will measure primary and secondary psychological outcomes prior to (T0), immediately after (T1), and twelve weeks after intervention (T2). Additionally, identified biomarkers will be measured at baseline and at T1, and T2.

CONDITIONS

Official Title

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

Who Can Participate

Age: 18Years - 39Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 to 39 years at time of consent
  • Male gender; self-identified
  • A confirmed diagnosis of cancer (any stage)
  • Diagnosed with cancer between the ages of 15 and 39
  • Hispanic/Latino identification
  • A score C= 1.8 on the Goal Navigation Scale or E= 4 on the Distress Thermometer
  • English or Spanish fluency
Not Eligible

You will not qualify if you...

  • Lifetime history of bipolar disorder, schizophrenia, or schizoaffective disorder (self-report)
  • Compromised cognitive capacity
  • Self-reported medical condition or medication use known to affect systemic inflammation (e.g., autoimmune disorder, active infection)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of California, Irvine

Irvine, California, United States, 92617

Actively Recruiting

Loading map...

Research Team

M

Michael A Hoyt, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here